Description
JUPIPLATIN-50
Oxaliplatin 50 mg Injection
FDA Approved Platinum-based antineoplastic
Great potential in malignancies such as:
Advanced ovarian cancer, Colorectal cancer
Advanced biliary adenocarcinoma in combination with Jupibine
Esophageal and gastric cancers in combination with Jupitaxel
Refractory testicular cancer in combination with Jupibine and Jupipac
